As a leading Jan Aushadhi supplier, we are committed to making high-quality, affordable medicines available to healthcare providers and patients across India. Contact us today for bulk orders and learn more about how we support the mission of affordable healthcare. The government should implement policies regorafenib price philippines that incentivize doctors to prescribe generic medicines. Additionally, healthcare professionals should be trained on the efficacy of generics to shift prescribing practices. Generic drugs in India must meet strict quality standards set by the Central Drugs Standard Control Organization (CDSCO).

Medicines for Kidney Problems

Due to the ability of the Indian pharma companies to produce drugs at economical rates, the cost of HIV/AIDS treatment has gone down to $400 per year from $12,000 – a spectacular contribution to global healthcare. Our generic drugs are priced competitively, without compromising quality, making life-saving treatments accessible. Generic medicines can only be produced after the patent on the brand-name drug has expired. This allows multiple manufacturers to create the same medicine, increasing competition and driving prices down. As of July 2024, ~13,113 Pradhan Mantri Bhartiya Janaushadhi Pariyojana Kendras were operational in India. Under the PMBJP Kendras, a medicine is priced on the principle of a maximum of 50% of the average price of the top three branded medicines.

How can I inquire about a specific medicine on Medkart Pharmacy?

Indian pharmaceutical companies manufacture a wide range of generic drugs, including antibiotics, antivirals, and medicines for chronic diseases like diabetes and hypertension. In India, generic pharmaceuticals are crucial to lowering healthcare costs and increasing access. We may better appreciate their vital function in the healthcare system if we are aware of their advantages, difficulties, and legal environment.

• Despite government efforts to promote generic medicines through initiatives like Jan Aushadhi Kendras, the availability of generics in rural and remote areas is still limited.
• The Indian government has taken several initiatives to promote the use of generic medicines domestically, including the Pradhan Mantri Jan Aushadhi Yojana (PMJAY), which provides quality generic medicines at affordable prices.
• The law was designed with the objective of stopping drug giants from indulging in ‘evergreening,’ an unfortunately common and abusive patenting practice in the pharmaceutical industry.
• All Generic and Branded Medicines and the rest of the essential medical products on Medkart Pharmacy are sourced directly from reputable manufacturers, ensuring authenticity and compliance with industry standards.
• In developing countries, India is rendering yeoman service by providing access to life saving medicines at affordable prices, he added.
• This allows multiple manufacturers to create the same medicine, increasing competition and driving prices down.

Lack of awareness

Indian manufacturers, with their reverse engineering skills, were the first to market low-cost versions of the life-saving cancer (Imatinib) and HIV drugs (Zidovudine) within a few years of their US launch. The Scheme is being implemented through the Bureau of Pharma PSUs of India (BPPI), under the administrative control of the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India. Over the years, India has developed a strong capability in producing quality branded and generic medicines in most of the therapeutic categories, evolving from a mere Rs 1,500 crores industry in 1980 to a more than Rs 1,19,000 crores industry in 2012.

Initiatives to support generics in India

The product basket presently comprises of 1,451 medicines and 240 surgical items covering all major therapeutic groups such as Cardiovascular, Anti-cancers, Anti-diabetics, Anti-infectives, Anti-allergic, Gastro-intestinal medicines, Nutraceuticals, etc. These medicines are available through more than 8,600 PMBJKs functioning across the country. In December 2023, the Department of Pharmaceuticals announced the availability of Jan Aushadhi Suvidha Oxo-Biodegradable Sanitary Napkins at Rs. 1 to ensure easy accessibility of and provide affordable sanitary napkins to women in India. From the beginning until November 30, 2023, more than 47.87 crore Jan Aushadhi Suvidha Sanitary Pads have been purchased from Jan Aushadhi Kendras. The scheme is being implemented by the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (BPPI), under the administrative control of the Department of Pharmaceuticals and the Ministry of Chemicals and Fertilisers. As of FY23, it covers 1,759 medicines and 280 surgical & consumables in all key therapeutic categories such as anti-infective, anti-allergic, anti-diabetics, cardiovascular, anti-cancers, and gastrointestinal medicines.

How can I be sure that the medicines on Medkart Pharmacy are genuine?

Indian pharmaceutical companies started exporting generic drugs to developing countries that were grappling with the high cost of healthcare. The country earned the title of the “pharmacy of the developing world”, providing essential medicines at low prices to countries in Africa, Asia, and Latin America. Yet, the country’s marginalised populations have limited access to medicines as branded medicines are sold at significantly higher prices than their unbranded generic equivalents, despite being identical in the therapeutic value. Therefore, there is an urgent need to ensure the availability of cheaper generics to citizens; this is in the best interest of these populations.

Are generic medicines as effective as brand-name ones?

• The potential of the PMBJP to expand and cover more medicines and medical devices is promising, and it can play a crucial role in achieving the goal of universal health coverage in India.
• Today, India is the world’s primary source of affordable HIV medicines as it is one of the few countries with the capacity to quickly produce newer HIV drugs as generics.
• The Government of India has taken up a number of initiatives to create an ecosystem that fosters manufacturing and have identified a few key areas.
• This makes them more accessible to patients and healthcare providers across different regions.
• There should be an unwavering commitment to high standards of quality in drug manufacturing and quality frameworks such as Good Manufacturing Practices should strictly be adhered to.
• Customer satisfaction, rooted in trust and clear communication, echoes concerns highlighted in global re-search, with a shared emphasis on addressing store-related issues.

Pharma companies should go above and beyond their CSR mandates to provide life saving and other essential drugs to those who cannot afford them. Our medications are sourced from Indian certified manufacturers and meet global regulatory standards. Our support team works tirelessly to assist patients and healthcare providers with their medication requirements.

Browse Medicines by Categories

‘Pharma Jan Samadhan’, a customer grievances redressal system was launched and a mobile application – ‘Pharma Sahi Daam’ that provides real-time information to consumers on prices of Scheduled/Non-scheduled medicines has also been introduced. Healthcare and its allied industries being the fifth-largest employer among all sectors, the Vice President asked the industry to invest in skilling. Given the significance of highly educated and specialized scientists in the sector, skill development is crucial, he said.

Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)

• Efficacy refers to the ability of medicines to produce desired therapeutic effects under ideal conditions.
• Availability involves the presence of essen-tial medicines in appropriate forms and quantities at healthcare facilities.
• Governments of developing countries have also initiated HIV treatment programmes using generically produced medicines from India.
• The only significant difference is the price, as generic drugs are often 30% to 90% cheaper than branded medicines.
• The government has proposed amendments to the Drugs and Cosmetics Rules to ensure availability of generic drugs at reasonable prices and to promote the use of generic medicines.
• However, there are still challenges that need to be addressed, such as ensuring the availability and accessibility of medicines in remote areas.
• Generic drugs have the same active ingredients as the brand-name drugs, ensuring the same therapeutic benefits.
• By the 1990s, India had become one of the largest suppliers of generic medicines globally.

It has led to significant cost savings for consumers and positive feedback from customers. However, challenges persist, including the need for greater awareness and addressing misconceptions. To further en-hance the program’s impact, efforts should focus on public awareness, supply-side regulations, and medicine pricing policies. Overall, the PMJAY has shown great potential in making healthcare more accessible and affordable, but con-tinuous improvements are necessary to achieve even better outcomes for the population. Generic medicines play a key role in government healthcare initiatives such as the Pradhan Mantri Jan Aushadhi Yojana (PMJAY), which aims to make essential medicines affordable and accessible to all citizens. By offering low-cost, high-quality alternatives to branded drugs, generic medicines help reduce healthcare costs and improve access to treatments, supporting the government’s broader goal of universal healthcare.

Apply for Pradhan Mantri Bhartiya Janaushadhi Kendra

ConclusionIn conclusion, the PMBJP scheme has been instrumental in making quality generic medicines available and affordable to all sections of society, especially the economically weaker sections in India. The scheme has been successful in increasing the accessibility of medicines to the masses and has helped in reducing healthcare costs for individuals and the government. However, there are still challenges that need to be addressed, such as ensuring the availability and accessibility of medicines in remote areas. The potential of the PMBJP to expand and cover more medicines and medical devices is promising, and it can play a crucial role in achieving the goal of universal health coverage in India.

FAQs about Generic Medicines In India

Recently, these initiatives have already been started by a few state governments in India. Developing countries across the world face several challenges, key among which is providing their people with affordable medicines of high-quality. You can purchase generic medicines at Jan Aushadhi Kendras (government-run stores) and most pharmacies across India. These stores offer a variety of affordable generic alternatives for common medicines.

The amendment reintroduced product patents for medicines, but India included provisions such as compulsory licensing, which allowed the production of generics for life-saving drugs in cases of public health emergencies. Rural health programmes, lifesaving drugs and preventive vaccines should also receive attention from policy makers and Pharma companies alike. Making quality medicines available at affordable prices for all, particularly the poor and disadvantaged, through exclusive outlets “Jan Aushadhi Medical Store”, so as to reduce out of pocket expenses in healthcare. For the benefit of the Indian population, DR BEST Pharmaceuticals also took a great initiative by starting their online pharmacy, which offers generic medicines with up to 80% discount at your doorsteps. The law was designed with the objective of stopping drug giants from indulging in ‘evergreening,’ an unfortunately common and abusive patenting practice in the pharmaceutical industry.

What is the focus of Medkart Pharmacy?

Under this scheme, Jan Aushadhi stores have been set up across India, where generic medicines are sold at affordable prices, making essential drugs accessible even in remote areas. They are accepted globally and are of the same quality with a lesser cost as compared to branded drugs. Moreover, it is easier to get generic medicines directly from online pharmacy 24/7 or in a nearby chemist shop. The generics prove to be a great alternative to branded medicines as they are bioequivalent or identical to branded drugs with comparable therapeutic action. Along with no compromise on quality, it is also cost-effective, as the cost of research and development and drug discovery is not included in the case of generic drugs.

The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) Scheme has introduced 2,047 medicines and 300 surgical devices, including cardiovascular, anti-cancer, and anti-diabetic treatments. The initiative aims to make essential medicines more accessible and affordable through resolute PMBJK outlets. While the Pradhan Mantri Jan Aushadhi Yojana (PMJAY) has promoted the use of generic medicines, there is still a lack of awareness about the benefits of generics among the general public and even some healthcare professionals. Many patients are unaware that generic medicines contain the same active ingredients as branded drugs and are equally effective. Generic medicines in India must adhere to the same regulatory standards as branded drugs. The Central Drugs Standard Control Organization (CDSCO) oversees the approval and regulation of generic medicines to ensure they meet high standards of safety, efficacy, and quality.

• Our medications are sourced from Indian certified manufacturers and meet global regulatory standards.
• It enabled Indian companies to manufacture medicines at much lower costs, without infringing on patents held by multinational corporations.
• Most people worry about the quality and effectiveness of generic medicines because generic drugs are not as costly as compared to branded drugs.
• I urge young researchers to work towards standardizing and benchmarking Indian systems of medicine.
• Many patients are unaware that generic medicines contain the same active ingredients as branded drugs and are equally effective.
• Regarding non-communicable diseases (NCDs), he outlined considerable progress in the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke.
• Yes, Medkart Pharmacy offers a diverse range of over-the-counter products to meet common health needs.

To address this issue government central government started Jan Aushadhi (Medicine for the masses) programme in 2008 with the objective of providing quality medicines at affordable prices. The research findings align with global efforts to enhance the accessibility, affordability, and acceptance of generic medi-cines, particularly through programs like India’s Jan Aushad-hi. Comparable challenges in affordability and availability resonate with international studies, emphasizing the need for continuous pricing policy review and effective public health policies. Customer satisfaction, rooted in trust and clear communication, echoes concerns highlighted in global re-search, with a shared emphasis on addressing store-related issues. [14]Collaborative efforts are crucial to fostering a comprehensive understand-ing and ensuring equitable access to generic medicines on a global scale.

The fixation of ceiling prices on medicines has resulted in a total saving of USD 392 million since May 2014. The Government of India has taken up a number of initiatives to create an ecosystem that fosters manufacturing and have identified a few key areas. ‘Make in India’ is one of the key programmes launched by the government to boost the economy and the aim is to transform India into a global manufacturing hub. This is an eloquent testimony to the competence of the Indian pharma sector in terms of quality and pricing. The Minister for Excise and Liquor Prohibition, Uttar Pradesh, Shri Jai Parata Singh and several dignitaries from fields of medicine, pharmaceuticals and other were present on the occasion.